Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Exploiting metabolic and antioxidant pathways to maintain vision in blinding disease
Pavitra S. Ramachandran, … , Ji Yun Song, Jean Bennett
Pavitra S. Ramachandran, … , Ji Yun Song, Jean Bennett
Published March 23, 2015
Citation Information: J Clin Invest. 2015;125(4):1390-1392. https://doi.org/10.1172/JCI80821.
View: Text | PDF
Commentary Article has an altmetric score of 1

Exploiting metabolic and antioxidant pathways to maintain vision in blinding disease

  • Text
  • PDF
Abstract

The use of gene therapy for blinding disease shows growing promise; however, due to an ever-expanding list of disease-causing genes and mutations, the identification of a generic gene-based treatment is urgently needed. In many forms of degenerative retinal disease, there may be a window of opportunity to preserve daylight vision, as the cone photoreceptors degenerate more slowly than do the rods. In this issue of the JCI, Venkatesh et al. and Xiong et al. exploit two different pathways to promote cone cell survival and preserve vision in murine retinal degeneration models. These studies provide hope for developing a universal reagent to treat many different blinding disorders.

Authors

Pavitra S. Ramachandran, Ji Yun Song, Jean Bennett

×

Figure 1

Prolonging cone survival to preserve vision.

Options: View larger image (or click on image) Download as PowerPoint
Prolonging cone survival to preserve vision.
(A) In many RP patients, th...
(A) In many RP patients, the loss of rod photoreceptors leads to night blindness. Secondary to this effect, there is reduced clearance of ROS, causing increased oxidative stress and nutrient shortage via decreased glucose metabolism in the outer segments. These two factors contribute to cone cell death over time. (B) Since cone cell death occurs slowly, there is a window of opportunity to preserve cone survival and function. The studies by Venkatesh et al. (5) and Xiong et al. (4) demonstrate that constitutive activation of mTORC1 or AAV-mediated NRF2 expression can extend cone survival and preserve cone outer segment morphology and function in mouse models of retinal degeneration. While mTORC1 activation targeted nutrient shortage in the cones by increasing glucose metabolism, NRF2 expression reduced ROS and decreased oxidative stress, thereby preserving cone vision.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
37 readers on Mendeley
See more details